Additionally, studies have shown that DPP4 inhibitors can effectively suppress ferroptosis in p53-deficient colorectal cancer cells, further emphasizing the critical role of the p53-DPP4 interaction in ferroptosis regulation [90]. This evidence concerns the gene TP53 and colorectal cancer.